ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
upcoming-policies-effective-july3-2023.pdf
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 1481 - 1490 လၢ 3685 အစၢတဖၣ်အကျါ
သဲစး ဒီး တၢ်ဖီၣ်ဂၢၢ်တၢ်သိၣ်တၢ်သီ
Blue Cross MN 2023 Annual Member Notice
တၢ်န့ၢ်ဘျုးဒီးတၢ်ဟ့ၣ်အဘူးအလဲ
Minnesota Senior Care Plus 2023 Spanish Member Handbook
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP34-23 Update for New to Market Medical Drugs: Tofersen
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 12, 2023
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 12, 2023
တၢ်န့ၢ်ဘျုးဒီးတၢ်ဟ့ၣ်အဘူးအလဲ
BlueRide Parent or Guardian Ride Consent Form
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P17-23 Inflation Reduction Act (IRA): Part B Rebatable Drugs and Part B Insulin Cap
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 03, 2023
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Rapid to Intermediate Acting Insulin - Commercial
Quantity Limit
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 01, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Rapid to Intermediate Acting Insulin - Medicaid
Quantity Limit
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 01, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Zoryve™ (roflumilast) - Commercial - Effective Date 02/01/2025
တချုးတၢ်ဟ့ၣ်စိဟ့ၣ်ကမီၤ
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 01, 2025